Phase I study of a novel schedule of capecitabine and docetaxel in patients with advanced solid tumors.

Trial Profile

Phase I study of a novel schedule of capecitabine and docetaxel in patients with advanced solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2009

At a glance

  • Drugs Capecitabine; Docetaxel
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Aug 2009 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 07 Aug 2006 Status change
    • 28 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top